Clinical aspects and comorbidities of psoriasis
- PMID: 19661531
- DOI: 10.3899/jrheum.090214
Clinical aspects and comorbidities of psoriasis
Abstract
Psoriasis is a disease mediated by Th1 and Th17 cytokines that has different phenotypes (plaque, guttate, pustular, and erythrodermic type). Aside from the well known psoriatic arthritis, associated disorders may occur more frequently than expected, including Crohn's disease, anxiety/depression, and metabolic syndrome. This is based on a constellation of different factors, including abdominal obesity, atherogenic dyslipidemia, hypertension, and glucose intolerance, and is a strong predictor of type 2 diabetes, cardiovascular disease, and stroke. People with moderate to severe psoriasis have more risk for cardiac disease, presumably due to the inflammatory nature of psoriasis, causing inflammatory changes in coronary arteries. The strong association between psoriasis and obesity potentially makes psoriasis an important healthcare issue. Since cardiovascular risk factors are higher in psoriatic patients, dermatologists treating moderate to severe psoriasis should screen for their presence, thus approaching psoriasis as a potential multisystem disorder.
Similar articles
-
Comorbidities in patients with psoriasis.Am J Med. 2009 Dec;122(12):1150.e1-9. doi: 10.1016/j.amjmed.2009.06.021. Am J Med. 2009. PMID: 19958894 Review.
-
Psoriasis comorbidities.J Dermatolog Treat. 2008;19(1):5-21. doi: 10.1080/09546630701364768. J Dermatolog Treat. 2008. PMID: 18273720 Review.
-
Long-term prognosis in patients with psoriasis.Br J Dermatol. 2008 Aug;159 Suppl 2:2-9. doi: 10.1111/j.1365-2133.2008.08779.x. Br J Dermatol. 2008. PMID: 18700909 Review.
-
Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review.Br J Dermatol. 2007 Oct;157(4):649-55. doi: 10.1111/j.1365-2133.2007.08068.x. Epub 2007 Jul 11. Br J Dermatol. 2007. PMID: 17627791 Review.
-
Psoriasis: cardiovascular risk factors and other disease comorbidities.J Drugs Dermatol. 2008 Apr;7(4):373-7. J Drugs Dermatol. 2008. PMID: 18459519
Cited by
-
Addressing comorbidities in psoriatic disease.Rheumatol Int. 2018 Feb;38(2):219-227. doi: 10.1007/s00296-017-3895-y. Epub 2017 Nov 28. Rheumatol Int. 2018. PMID: 29185085
-
Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controls.An Bras Dermatol. 2019 Mar-Apr;94(2):192-197. doi: 10.1590/abd1806-4841.20197716. Epub 2019 May 9. An Bras Dermatol. 2019. PMID: 31090824 Free PMC article.
-
Which Psoriasis Patients Develop Psoriatic Arthritis?Psoriasis Forum. 2010 Winter;16(4):17-25. Psoriasis Forum. 2010. PMID: 25346592 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical